Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jordan Gauthier

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Bulletin Du Cancer|January 29, 2019
Jordan Gauthier
Bone Marrow Transplantation|July 22, 2021
Current combinatorial CAR T cell strategies with Bruton tyrosine kinase inhibitors and immune checkpoint inhibitorsRazan Mohty, Jordan Gauthier
Cancer Journal (Sudbury, Mass.)|March 22, 2021
Chimeric Antigen Receptor T-Cell Therapy for B-Cell Acute Lymphoblastic Leukemia: Current Landscape in 2021Jordan Gauthier, Cameron J Turtle
Hematology/Oncology Clinics of North America|August 31, 2020
Allogeneic Transplantation and Chimeric Antigen Receptor-Engineered T-Cell Therapy for Relapsed or Refractory Mantle Cell LymphomaJordan Gauthier, David G Maloney
Current Research in Translational Medicine|April 8, 2018
Insights into cytokine release syndrome and neurotoxicity after CD19-specific CAR-T cell therapyJordan Gauthier, Cameron J Turtle
Nature Reviews. Clinical Oncology|November 15, 2022
Clash of the titans: axi-cel versus tisa-cel for advanced-stage DLBCLRichard T Maziarz, Jordan Gauthier
Bone Marrow Transplantation|November 24, 2020
Taming the beast: CRS and ICANS after CAR T-cell therapy for ALLVipul S Sheth, Jordan Gauthier
Bulletin Du Cancer|March 24, 2015
[The role of pre-transplant debulking treatment in patients undergoing allogeneic stem cell transplantation for high-risk myelodysplastic syndrome]Jordan Gauthier, Gandhi Damaj, Ibrahim Yakoub-Agha
Bulletin Du Cancer|August 11, 2011
[IMiDs in hematology]Mathieu Wémeau, Jordan Gauthier, Xavier Leleu, et al.
Expert Review of Hematology|April 6, 2022
Managing hypogammaglobulinemia in patients treated with CAR-T-cell therapy: key points for cliniciansEleftheria Kampouri, Carla S Walti, Jordan Gauthier, et al.
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Bulletin Du Cancer|January 29, 2019
Jordan Gauthier
Bone Marrow Transplantation|July 22, 2021
Current combinatorial CAR T cell strategies with Bruton tyrosine kinase inhibitors and immune checkpoint inhibitorsRazan Mohty, Jordan Gauthier
Cancer Journal (Sudbury, Mass.)|March 22, 2021
Chimeric Antigen Receptor T-Cell Therapy for B-Cell Acute Lymphoblastic Leukemia: Current Landscape in 2021Jordan Gauthier, Cameron J Turtle
Hematology/Oncology Clinics of North America|August 31, 2020
Allogeneic Transplantation and Chimeric Antigen Receptor-Engineered T-Cell Therapy for Relapsed or Refractory Mantle Cell LymphomaJordan Gauthier, David G Maloney
Current Research in Translational Medicine|April 8, 2018
Insights into cytokine release syndrome and neurotoxicity after CD19-specific CAR-T cell therapyJordan Gauthier, Cameron J Turtle
Nature Reviews. Clinical Oncology|November 15, 2022
Clash of the titans: axi-cel versus tisa-cel for advanced-stage DLBCLRichard T Maziarz, Jordan Gauthier
Bone Marrow Transplantation|November 24, 2020
Taming the beast: CRS and ICANS after CAR T-cell therapy for ALLVipul S Sheth, Jordan Gauthier
Bulletin Du Cancer|March 24, 2015
[The role of pre-transplant debulking treatment in patients undergoing allogeneic stem cell transplantation for high-risk myelodysplastic syndrome]Jordan Gauthier, Gandhi Damaj, Ibrahim Yakoub-Agha
Bulletin Du Cancer|August 11, 2011
[IMiDs in hematology]Mathieu Wémeau, Jordan Gauthier, Xavier Leleu, et al.
Expert Review of Hematology|April 6, 2022
Managing hypogammaglobulinemia in patients treated with CAR-T-cell therapy: key points for cliniciansEleftheria Kampouri, Carla S Walti, Jordan Gauthier, et al.
Pageof 9